Camden Capital, LLC Merck & Co., Inc. Transaction History

Camden Capital, LLC

  • $1.14 Billion
  • Q1 2024

A detailed history of Camden Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Camden Capital, LLC holds 13,557 shares of MRK stock, worth $1.71 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
13,557
Previous 16,278 16.72%
Holding current value
$1.71 Million
Previous $1.77 Million 0.79%
% of portfolio
0.16%
Previous 0.18%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$113.24 - $131.95 $308,126 - $359,035
-2,721 Reduced 16.72%
13,557 $1.79 Million
Q4 2023

Feb 05, 2024
BUY
$100.18 - $109.02 $920,654 - $1 Million
9,190 Added 129.66%
16,278 $1.77 Million
Q3 2023

Nov 03, 2023
BUY
$102.95 - $114.33 $126,319 - $140,282
1,227 Added 20.93%
7,088 $729,000
Q2 2023

Aug 09, 2023
BUY
$108.61 - $118.38 $223,845 - $243,981
2,061 Added 54.24%
5,861 $676,000
Q1 2023

May 11, 2023
BUY
$102.94 - $114.86 $29,852 - $33,309
290 Added 8.26%
3,800 $404,000
Q4 2022

Feb 13, 2023
SELL
$87.44 - $112.11 $147,598 - $189,241
-1,688 Reduced 32.47%
3,510 $389,000
Q3 2022

Nov 08, 2022
BUY
$84.53 - $94.96 $127,217 - $142,914
1,505 Added 40.75%
5,198 $448,000
Q2 2022

Aug 03, 2022
SELL
$83.49 - $94.64 $274,348 - $310,987
-3,286 Reduced 47.08%
3,693 $337,000
Q1 2022

May 06, 2022
BUY
$73.51 - $82.4 $23,449 - $26,285
319 Added 4.79%
6,979 $573,000
Q4 2021

Feb 28, 2022
SELL
$72.28 - $90.54 $341,017 - $427,167
-4,718 Reduced 41.47%
6,660 $510,000
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $38,742 - $48,529
536 Added 4.94%
11,378 $872,000
Q3 2021

Nov 03, 2021
BUY
$71.68 - $78.83 $196,833 - $216,467
2,746 Added 33.92%
10,842 $814,000
Q2 2021

Aug 16, 2021
BUY
$70.31 - $77.77 $140,127 - $154,995
1,993 Added 32.66%
8,096 $630,000
Q1 2021

May 10, 2021
BUY
$68.86 - $81.11 $33,534 - $39,500
487 Added 8.67%
6,103 $471,000
Q4 2020

Feb 04, 2021
BUY
$71.77 - $79.65 $33,731 - $37,435
470 Added 9.13%
5,616 $459,000
Q3 2020

Oct 30, 2020
BUY
$73.18 - $82.95 $120,893 - $137,033
1,652 Added 47.28%
5,146 $427,000
Q2 2020

Aug 11, 2020
SELL
$70.42 - $80.13 $15,633 - $17,788
-222 Reduced 5.97%
3,494 $270,000
Q1 2020

Apr 13, 2020
SELL
$63.36 - $87.82 $95,103 - $131,817
-1,501 Reduced 28.77%
3,716 $286,000
Q4 2019

Feb 10, 2020
BUY
$77.58 - $87.54 $404,734 - $456,696
5,217 New
5,217 $474,000

Others Institutions Holding MRK

# of Institutions
3,769
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email